Skip to main content
S 741 116th Congress Senate Health Cancer Drug therapy Health care costs and insurance Health care coverage and access Prescription drugs

Cancer Drug Parity Act of 2019

Introduced: March 12, 2019 Introduced by: Smith, Tina Democratic · Minnesota See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 12, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 12, 2019
Introduced in Senate
 Plain-English summary Congressional Research Service

Cancer Drug Parity Act of 2019

This bill requires health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent site, and duration.

To comply with this requirement, health plans may not, with respect to anticancer medications (1) change or replace benefits to increase out-of-pocket costs, (2) reclassify benefits to increase costs, or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.
What's happening now March 12, 2019

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 1